PROZAC WEEKLY Drug Patent Profile
✉ Email this page to a colleague
When do Prozac Weekly patents expire, and what generic alternatives are available?
Prozac Weekly is a drug marketed by Lilly and is included in one NDA.
The generic ingredient in PROZAC WEEKLY is fluoxetine hydrochloride. There are twenty-seven drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the fluoxetine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Prozac Weekly
A generic version of PROZAC WEEKLY was approved as fluoxetine hydrochloride by APNAR PHARMA LP on August 2nd, 2001.
Summary for PROZAC WEEKLY
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 174 |
Clinical Trials: | 110 |
Patent Applications: | 5,589 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PROZAC WEEKLY at DailyMed |
Recent Clinical Trials for PROZAC WEEKLY
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Avy L. & Roberta L. Miller Foundation | Phase 2 |
Stanford University | Phase 2 |
Milton S. Hershey Medical Center | Early Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for PROZAC WEEKLY
US Patents and Regulatory Information for PROZAC WEEKLY
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | PROZAC WEEKLY | fluoxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 021235-001 | Feb 26, 2001 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PROZAC WEEKLY
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Lilly | PROZAC WEEKLY | fluoxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 021235-001 | Feb 26, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
Lilly | PROZAC WEEKLY | fluoxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 021235-001 | Feb 26, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
Lilly | PROZAC WEEKLY | fluoxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 021235-001 | Feb 26, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PROZAC WEEKLY
See the table below for patents covering PROZAC WEEKLY around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Greece | 980100188 | ⤷ Try a Trial | |
Denmark | 176776 | ⤷ Try a Trial | |
Switzerland | 693018 | Magensäureresistente Fluoxetinpellets | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |